Shunichiro Matsumoto is the CEO of Ono Venture Investment, the corporate venture capital arm of Ono Pharmaceutical Co. , Ltd. He leverages his Ph. D. and McGill University MBA to drive investments in biotech. His background includes extensive experience in discovery research and alliance management within the pharmaceutical industry.
He recently led the strategic expansion of Ono Venture Investments fund to US$200 million, significantly increasing its capacity to support early-stage drug discovery companies.
Read the full overview →Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.
Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.
Discover additional public profiles from our index.
Looking for someone else? Search here for anyone.